Home
>
National Drug Code (NDC)
>
Pioglitazone
Pioglitazone - 0093-2046-56 - (pioglitazone)
Drug Information of Pioglitazone
| Product NDC: | 0093-2046 |
| Proprietary Name: | Pioglitazone |
| Non Proprietary Name: | pioglitazone |
| Active Ingredient(s): | 45 mg/1 & nbsp; pioglitazone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pioglitazone
| Product NDC: | 0093-2046 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021073 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20120817 |
Package Information of Pioglitazone
| Package NDC: | 0093-2046-56 |
| Package Description: | 30 TABLET in 1 BOTTLE (0093-2046-56) |
NDC Information of Pioglitazone
| NDC Code | 0093-2046-56 |
| Proprietary Name | Pioglitazone |
| Package Description | 30 TABLET in 1 BOTTLE (0093-2046-56) |
| Product NDC | 0093-2046 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | pioglitazone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20120817 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | PIOGLITAZONE HYDROCHLORIDE |
| Strength Number | 45 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient] |
